ACE2 and Hepatic fibrosis: In SD rats receiving BDL, a rat model of liver fibrosis, hepatic ACE2 mRNA was within the no/marginal change level, which was increased by losartan to the barely overexpression level [102], whereas hepatic ACE2 protein was overexpressed and augmented further by telmisartan [103].